These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29463368)

  • 1. Preparation and Biocompatibility Evaluation of PEG-PLL/RGD-PEG-DSPE/Phospholipid/CaP Nanoparticles.
    Huang J; Zhang X; Wu Z; Wu Y; Wu X; Wang Y; Jiang H; Ma J; He Z
    J Biomed Nanotechnol; 2018 Jan; 14(1):98-113. PubMed ID: 29463368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.
    Zhang X; He Z; Xiang L; Li L; Zhang H; Lin F; Cao H
    Drug Des Devel Ther; 2019; 13():1357-1372. PubMed ID: 31118572
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and properties of biocompatible PS-PEG/calcium phosphate nanospheres.
    Wang Q; Liu P; Sun Y; Gong T; Zhu M; Sun X; Zhang Z; Duan Y
    Nanotoxicology; 2015 Mar; 9(2):190-200. PubMed ID: 24787691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indocyanine green loaded SPIO nanoparticles with phospholipid-PEG coating for dual-modal imaging and photothermal therapy.
    Ma Y; Tong S; Bao G; Gao C; Dai Z
    Biomaterials; 2013 Oct; 34(31):7706-14. PubMed ID: 23871538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of paclitaxel-loaded DSPE-PEG-liquid crystalline nanoparticles (LCNPs) for improved bioavailability.
    Zeng N; Hu Q; Liu Z; Gao X; Hu R; Song Q; Gu G; Xia H; Yao L; Pang Z; Jiang X; Chen J; Fang L
    Int J Pharm; 2012 Mar; 424(1-2):58-66. PubMed ID: 22240390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composition-dependent structural changes and antitumor activity of ASC-DP/DSPE-PEG nanoparticles.
    Higashi K; Mibu F; Saito K; Limwikrant W; Yamamoto K; Moribe K
    Eur J Pharm Sci; 2017 Mar; 99():24-31. PubMed ID: 27916697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[Methoxy(polyethylene glycerol)-2000] and Its Complex with Doxorubicin Using Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics.
    Hu W; Mao A; Wong P; Larsen A; Yazaki PJ; Wong JYC; Shively JE
    Bioconjug Chem; 2017 Jun; 28(6):1777-1790. PubMed ID: 28520406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of DSPE-PEG on compound action potential, injury potential and ion concentration following compression in ex vivo spinal cord.
    Wang A; Huo X; Zhang G; Wang X; Zhang C; Wu C; Rong W; Xu J; Song T
    Neurosci Lett; 2016 May; 620():50-6. PubMed ID: 27021025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model.
    Dong Z; Guo J; Xing X; Zhang X; Du Y; Lu Q
    Biomed Pharmacother; 2017 May; 89():297-304. PubMed ID: 28236703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ascorbyl palmitate/DSPE-PEG nanocarriers for oral iron delivery: preparation, characterisation and in vitro evaluation.
    Zariwala MG; Farnaud S; Merchant Z; Somavarapu S; Renshaw D
    Colloids Surf B Biointerfaces; 2014 Mar; 115():86-92. PubMed ID: 24333557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of mixed micelles formed in PEG-lipid/lipid dispersions.
    Sandström MC; Johansson E; Edwards K
    Langmuir; 2007 Apr; 23(8):4192-8. PubMed ID: 17343401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RGD-containing peptide GCRGYGRGDSPG reduces enhancement of osteoblast differentiation by poly(L-lysine)-graft-poly(ethylene glycol)-coated titanium surfaces.
    Tosatti S; Schwartz Z; Campbell C; Cochran DL; VandeVondele S; Hubbell JA; Denzer A; Simpson J; Wieland M; Lohmann CH; Textor M; Boyan BD
    J Biomed Mater Res A; 2004 Mar; 68(3):458-72. PubMed ID: 14762925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper sulfide nanoparticles with phospholipid-PEG coating for in vivo near-infrared photothermal cancer therapy.
    Huang Y; Lai Y; Shi S; Hao S; Wei J; Chen X
    Chem Asian J; 2015 Feb; 10(2):370-6. PubMed ID: 25425287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
    Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
    Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.
    Jin Y; Wu Z; Li C; Zhou W; Shaw JP; Baguley BC; Liu J; Zhang W
    Pharm Res; 2018 Jan; 35(1):13. PubMed ID: 29302821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA.
    Choi YH; Liu F; Choi JS; Kim SW; Park JS
    Hum Gene Ther; 1999 Nov; 10(16):2657-65. PubMed ID: 10566893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.